Chest
Volume 133, Issue 6, Supplement, June 2008, Pages 708S-775S
SupplementAntithrombotic and Thrombolytic Therapy 8th ED: ACCP GuidelinesAcute ST-Segment Elevation Myocardial Infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Antithrombotic and Thrombolytic Therapy 8th ED: ACCP Guidelines
Section snippets
Reperfusion Therapy
1.0.1. For patients with ischemic symptoms characteristic of acute MI of ≤ 12 h duration and persistent STE, we recommend that all undergo rapid evaluation for reperfusion (primary PCI or fibrinolytic) therapy and have a reperfusion strategy implemented promptly after contact with the health-care system (Grade 1A).
Fibrinolysis
1.1.1. In patients with acute MI who are candidates for fibrinolytic therapy, we recommend administration as soon as possible (ideally within 30 min) after arrival to the hospital or
References (271)
- et al.
Acute myocardial infarction
Lancet
(2003) - et al.
Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty
J Am Coll Cardiol
(2003) - et al.
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
Lancet
(2003) - et al.
Long-term outcome after primary angioplasty: report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) trial
J Am Coll Cardiol
(1999) - et al.
Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?
Am J Cardiol
(2003) - et al.
Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy
Am J Cardiol
(1991) - et al.
Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: anglo-Scandanavian study of early thrombolysis (ASSET)
Lancet
(1988) - et al.
on behalf of Urochinasi per via Sistemica nell'Infarto Miocardico (USIM) Collaborative Group. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction
Am J Cardiol
(1991) - et al.
Thrombolytic therapy in older patients
J Am Coll Cardiol
(2000) Thrombolytic therapy in the elderly
Lancet
(2000)
Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study
J Am Coll Cardiol
(1990)
Prehospital thrombolysis in acute myocardial infarction
Am J Cardiol
(1990)
Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction
Am J Cardiol
(1990)
Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study
Lancet
(2002)
Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT)
J Am Coll Cardiol
(1994)
Evaluation of the time saved byprehospital initiation of reteplase for ST-elevation myocardial infarction: results of the early retavase-thrombolysisin myocardial infarction (ER-TIMI) 19 trial
J Am Coll Cardiol
(2002)
Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour
Lancet
(1996)
The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III registry ECG ancillary study
J Am Coll Cardiol
(1997)
Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes
J Am Coll Cardiol
(2005)
A comprehensive analysis of myocardial infarction due to left circumflex artery occlusion: comparison with infarction due to right coronary artery and left anterior descending artery occlusion
J Am Coll Cardiol
(1988)
Significance of ST segment elevations in posterior chest leads (V7 to V9) in patients with acute inferior myocardial infarction: application for thrombolytic therapy
J Am Coll Cardiol
(1998)
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography)
J Am Coll Cardiol
(2003)
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy
Lancet
(1993)
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage
Am Heart J
(2001)
New heparin dosing recommendations for patients with acute coronary syndromes
Am J Med
(2001)
Incidence, risk factors, and clinical outcome of stroke after acute myocardial infarction in clinical practice
Am J Cardiol
(2001)
Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project
Am Heart J
(2004)
A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction
Am J Cardiol
(1994)
Improved thrombolysis with a modified dose regiment of recombinant tissue-type plasminogen activator
J Am Coll Cardiol
(1989)
Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction: rAAMI Study Investigators
J Am Coll Cardiol
(1992)
Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)
J Am Coll Cardiol
(1992)
Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial
J Am Coll Cardiol
(1994)
Lancet
(1988)
Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts
Circulation
(2004)
Treatment delayed is treatment denied
Circulation
(2004)
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction)
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review
JAMA
(1997)
Am Heart J
(2003)
A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
N Engl J Med
(1993)
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
N Engl J Med
(1993)
Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction
N Engl J Med
(1993)
Coronary angioplasty with or without stent implantation for acute myocardial infarction
N Engl J Med
(1999)
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction
N Engl J Med
(2002)
Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction
N Engl J Med
(1999)
Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study)
Can J Cardiol
(2003)
The Primary Coronary Angioplasty vs Thrombolysis (PCAT)-2 Trialists' Collaborative Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients
Eur Heart J
(2006)
Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis
Circulation
(2005)
The volume of primary angioplasty procedures and survival after acute myocardial infarction
N Engl J Med
(2000)
Relation between hospital primary angioplasty volume and mortality for patients with acute mi treated with primary angioplasty vs thrombolytic therapy
JAMA
(2000)
Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis
JAMA
(2003)
Cited by (0)
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml).
Copyright © 2008 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.